Metagenomi Therapeutics, Inc. (MGX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $158.60M | -32.5% |
| 2024 | $234.86M | +273.2% |
| 2023 | -$135.58M | -82.2% |
| 2022 | -$74.43M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $158.60M | -32.5% |
| 2024 | $234.86M | +273.2% |
| 2023 | -$135.58M | -82.2% |
| 2022 | -$74.43M | — |